Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
After obtaining a B.S. with honors in Electrical Engineering, Richard C. Burgess received the Ph.D. in Biomedical Engineering and M.D. degrees from Case Western Reserve University in 1975 and 1977 respectively and completed his residency at University Hospitals of Cleveland in 1980. From 1980 to 1986, he was at the National Institutes of Health investigating computer techniques for neurophysiological monitoring of intensive care patients.
In 1986 he joined the Professional Staff in the Department of Neurology at the Cleveland Clinic Foundation. Dr. Burgess formed a group responsible for applications of computers to clinical neurophysiology and clinical information support systems. From 1990 to 2004, Dr Burges was Head, Section of Neurological Computing at the Cleveland Clinic, technical director of the Epilepsy Monitoring Unit at the v.Bodeschwingsche Anstalten Bethel in Bielefeld, Germany, and Associate Editor of the Journal of Clinical Neurophysiology.
In addition, Dr. Burgess was president of Vangard, a commercial entity formed in 1994 as an outgrowth of the technology which was developed by the Section of Neurological Computing for assessment of patients with epilepsy and other neurological disorders. Vangard was sold into the private sector in 2000. Dr. Burgess has leadership and board positions in the American Epilepsy Society and the American Clinical MEG Society, and he is a member of the the American Clinical Neurophysiological Society, the IEEE Engineering in Medicine and Biology Society, the American Academy of Neurology, and the American Medical Association.
Most recently, he has been responsible for bringing to the Cleveland Clinic magnetoencephalography, a sophisticated functional measurement system for assessing normal and abnormal brain function. The MEG system was installed at CCF in 2008, and Dr. Burgess now conducts assessments of more patients with complicated epilepsy than at any other center, totalling over 400 by 2011.
clinical neurophysiology, computer processing of electrophysiologic signals, continuous computerized neurophysiologic assessment, dipole modeling, EEG, EEG/MEG and related translational research, Epilepsy, forward modeling of electrophysiological signals, magnetoencephalography, medical informatics, MEG, principal components analysis, Sleep Disorders, telemedicine
Innovations & Patents
Dr Burgess developed a comprehensive, computerized EEG-video recording and analysis system for continuous monitoring of patients with neurological disorders, used at the Cleveland Clinic for 18 years, and sold in seven countries as the "Vangard System".
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/13/2015, Dr. Burgess has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.